Integrating AI and Machine Learning into Pharma R&D | Thought Leadership | ICON plc

ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.

Related Information

AI and Clinical Trials

The Impact of Artificial Intelligence on Outcomes Based Contracting

Can AI improve R&D productivity enough to restore ROI to sustainable levels?

Alexa… What’s the deal with voice assistants?

Connect with us